SCHEMBL10064828

SCHEMBL10064828

Cc1cccc(N(c2ccccc2)c2ccc(-c3ccc(N(c4ccccc4)c4ccc(O)cc4)cc3)cc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP3 P08254 1/20 0.45
BCL2L1 Q07817 1/20 0.45
HSD17B1 P14061 2/20 0.43
HSD17B2 P37059 2/20 0.43
ESR1 P03372 4/20 0.42
ACHE P22303 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41
LTB4R2 Q9NPC1 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12268827 1.00 MMP3 (0.45) MMP3BCL2L1HSD17B1HSD17B2ESR1
SCHEMBL15315168 1.00 MMP3 (0.45) MMP3BCL2L1HSD17B1HSD17B2ESR1
SCHEMBL2245873 0.97 ESR1 (0.45) MMP3BCL2L1HSD17B1HSD17B2ESR1
SCHEMBL22942236 0.93 CYP1A2 (0.45) HSD17B1HSD17B2ESR1ACHEMEN1
SCHEMBL2609917 0.92 ACHE (0.50) HSD17B1HSD17B2ACHEPOLBMAPT
SCHEMBL2609916 0.92 ACHE (0.50) HSD17B1HSD17B2ACHEPOLBMAPT
SCHEMBL148955 0.91 HSD17B1 (0.45) HSD17B1HSD17B2ACHEMEN1KMT2A
SCHEMBL22356719 0.91 HSD17B1 (0.45) HSD17B1HSD17B2ACHEMEN1KMT2A
SCHEMBL5840586 0.91 HSD17B1 (0.45) HSD17B1HSD17B2ACHEMEN1KMT2A
SCHEMBL21922635 0.91 HSD17B1 (0.45) HSD17B1HSD17B2ACHEMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170329199-A1 ELECTROCHROMIC DEVICE RICOH COMPANY, LTD. (JP) 2017-11-16 US disclosed
US-20170329198-A1 ELECTROCHROMIC ELEMENT RICOH COMPANY, LTD. (JP) 2017-11-16 US disclosed
US-20170235203-A1 ELECTROCHROMIC ELEMENT AND ELECTROCHROMIC DIMMING ELEMENT RICOH COMPANY, LTD. (JP) 2017-08-17 US disclosed
EP-2412674-A1 INORGANIC MATERIAL, DEVICE, AND ORGANIC ELECTROLUMINESCENT ELEMENT FUJIFILM Corporation (JP) 2012-02-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170235203-A1 ELECTROCHROMIC ELEMENT AND ELECTROCHROMIC DIMMING ELEMENT TET2, TET1, TET3 MMP3 2012/4885BCL2L1 4366/4885HSD17B1 1784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.